Perceived Satiety and Consumer Sensory Acceptance of Functional Foods Enriched With Edible Insect and Plant Proteins
NOODLE
Assessment of the Impact of Functional Foods Enriched With Cricket and Pea Proteins on Perceived Satiety and Consumer Sensory Acceptance
1 other identifier
interventional
100
1 country
1
Brief Summary
This randomized, single-blind, triple crossover study investigated the effects of baked snacks containing either cricket flour (Acheta domesticus), pea flour (both at 15%), or a wheat flour-based control. One hundred adult participants were recruited and consumed each of the three products across separate sessions. Data were collected on sociodemographic characteristics, hunger and satiety perceptions using visual analogue scales (VAS), gastrointestinal tolerability via a post-consumption questionnaire, hedonic liking assessed with a 9-point scale, and sensory and emotional responses using Check-All-That-Apply (CATA) questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 24, 2025
CompletedFirst Submitted
Initial submission to the registry
September 11, 2025
CompletedFirst Posted
Study publicly available on registry
September 18, 2025
CompletedSeptember 29, 2025
September 1, 2025
4 months
September 11, 2025
September 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postprandial Subjective Satiety Perception
Satiety perception will be assessed using the Visual Analogue Scale (VAS; 0-100 mm), where 0 = "not satiated at all" and 100 = "extremely satiated". Higher scores indicate greater satiety.
60, 120, 180, 240, and 300 minutes post-consumption.
Postprandial Hunger
Hunger perception will be assessed using the Visual Analogue Scale (VAS; 0-100 mm), where 0 = "not hungry at all" and 100 = "extremely hungry". Higher scores indicate greater hunger.
60, 120, 180, 240, and 300 minutes post-consumption.
Postprandial Gastric Fullness
Gastric fullness perception will be assessed using the Visual Analogue Scale (VAS; 0-100 mm), where 0 = "not full at all" and 100 = "extremely full". Higher scores indicate greater fullness.
60, 120, 180, 240, and 300 minutes post-consumption.
Prospective Food Consumption
Prospective food consumption will be assessed using the Visual Analogue Scale (VAS; 0-100 mm), where 0 = "no desire to eat at all" and 100 = "extreme desire to eat". Higher scores indicate greater desire for food intake.
60, 120, 180, 240, and 300 minutes post-consumption.
Secondary Outcomes (3)
Gastrointestinal Symptoms Evaluation
Within 24 hours after snack intake.
Sensory Acceptability
Immediately after snack consumption.
Emotional and Descriptive Food Experience
Immediately after snack consumption.
Study Arms (3)
Cricket Flour-Enriched Snack
EXPERIMENTALsavory snack enriched with 15% cricket flour
Pea Flour-Enriched Snack
EXPERIMENTALsavory snack enriched with 15% pea flour
Control Snack (Wheat Flour-Based)
PLACEBO COMPARATORconventional savory snack made of wheat flour.
Interventions
Consumption of a single 50-gram portion of a wheat flour-based control snack.
Consumption of a single 50-gram portion of a snack enriched with 15% cricket flour (Acheta domesticus).
Consumption of a single 50-gram portion of a snack enriched with 15% pea flour.
Eligibility Criteria
You may qualify if:
- Healthy volunteer subjects aged between 18 and 65 years;
- Body mass index (BMI) between 18.5 and 29.9 kg/m²
You may not qualify if:
- Diagnosis of diabetes mellitus;
- Thyroid disorders;
- Food allergies;
- Gastrointestinal and/or systemic diseases (including renal, hepatic, cardiovascular, or any other organ-related conditions);
- Regular use of medications or dietary supplements;
- Pregnancy or lactation;
- Following specific dietary regimens (vegetarian or vegan).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Torino
Torino, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2025
First Posted
September 18, 2025
Study Start
November 10, 2024
Primary Completion
March 20, 2025
Study Completion
July 24, 2025
Last Updated
September 29, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share